Shipeng Ning
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
Papers in ⓘ
-
- Nanoplatforms for cancer theranostics 49
-
- Extracellular vesicles in disease 8
- RNA modifications and cancer 6
- Co-authors
- Meng Lyu (12 shared papers)Shouping Xu (9 shared papers)Daoming Zhu (9 shared papers)Tianfu Zhang (8 shared papers)Jacky W. Y. Lam (5 shared papers)Da Pang (6 shared papers)Ben Zhong Tang (9 shared papers)Qinqin Huang (4 shared papers)
In The Last Decade
Shipeng Ning
60 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 386
- Biomedical Engineering 673
- Biomaterials 176
- Molecular Biology 643
- Materials Chemistry 362
Countries citing papers authored by Shipeng Ning
This map shows the geographic impact of Shipeng Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipeng Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipeng Ning more than expected).
Fields of papers citing papers by Shipeng Ning
This network shows the impact of papers produced by Shipeng Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipeng Ning. The network helps show where Shipeng Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Shipeng Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge Hit paper breakdown → | 2023 | 207 |
| 2 | 2019 | 127 | |
| 3 | 2017 | 111 | |
| 4 | 2022 | 77 | |
| 5 | 2023 | 63 | |
| 6 | 2019 | 52 | |
| 7 | 2022 | 47 | |
| 8 | 2020 | 46 | |
| 9 | 2024 | 43 | |
| 10 | 2023 | 42 | |
| 11 | 2023 | 41 | |
| 12 | 2021 | 34 | |
| 13 | 2023 | 32 | |
| 14 | 2024 | 31 | |
| 15 | Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer Hit paper breakdown → | 2025 | 30 |
| 16 | 2021 | 29 | |
| 17 | 2021 | 25 | |
| 18 | 2023 | 24 | |
| 19 | 2024 | 24 | |
| 20 | 2024 | 24 |
About Shipeng Ning
Shipeng Ning is a scholar working on Biomedical Engineering, Molecular Biology, Materials Chemistry, Pulmonary and Respiratory Medicine and Cancer Research, having authored 67 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (49 papers), Advanced Nanomaterials in Catalysis (20 papers), Nanoparticle-Based Drug Delivery (9 papers), Photodynamic Therapy Research Studies (9 papers), Extracellular vesicles in disease (8 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and Luminescence and Fluorescent Materials (6 papers). The work is most often cited by research in Cancer Research (386 citations), Biomedical Engineering (673 citations), Biomaterials (176 citations), Molecular Biology (643 citations) and Materials Chemistry (362 citations). Shipeng Ning has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Meng Lyu, Shouping Xu, Daoming Zhu, Tianfu Zhang, Jacky W. Y. Lam, Da Pang, Ben Zhong Tang, Qinqin Huang, Qin Wang and Pan You. Their work appears in journals such as Advanced Science, Chemical Engineering Journal, International Journal of Nanomedicine, Nano Today and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.